213 related articles for article (PubMed ID: 16555582)
1. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats.
Nakano S; Kobayashi N; Yoshida K; Ohno T; Matsuoka H
Hypertens Res; 2005 Nov; 28(11):925-36. PubMed ID: 16555582
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats.
Mita S; Kobayashi N; Yoshida K; Nakano S; Matsuoka H
J Hypertens; 2005 Jan; 23(1):87-96. PubMed ID: 15643129
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts.
Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H
Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
[TBL] [Abstract][Full Text] [Related]
5. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
[TBL] [Abstract][Full Text] [Related]
6. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
Onozato ML; Tojo A; Kobayashi N; Goto A; Matsuoka H; Fujita T
Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946
[TBL] [Abstract][Full Text] [Related]
7. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway.
Kobayashi N; Hara K; Tojo A; Onozato ML; Honda T; Yoshida K; Mita S; Nakano S; Tsubokou Y; Matsuoka H
Hypertension; 2005 Apr; 45(4):538-44. PubMed ID: 15710785
[TBL] [Abstract][Full Text] [Related]
8. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition.
Kobayashi N; Honda T; Yoshida K; Nakano S; Ohno T; Tsubokou Y; Matsuoka H
Atherosclerosis; 2006 Jul; 187(1):92-100. PubMed ID: 16214149
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats.
Kobayashi N; Nakano S; Mita S; Kobayashi T; Honda T; Tsubokou Y; Matsuoka H
J Pharmacol Exp Ther; 2002 May; 301(2):459-66. PubMed ID: 11961044
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels.
Rivera P; Ocaranza MP; Lavandero S; Jalil JE
Hypertension; 2007 Oct; 50(4):792-8. PubMed ID: 17785632
[TBL] [Abstract][Full Text] [Related]
11. Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt-induced hypertensive rat.
Park YM; Lim BH; Touyz RM; Park JB
J Korean Med Sci; 2008 Dec; 23(6):1039-45. PubMed ID: 19119450
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
13. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A
Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192
[TBL] [Abstract][Full Text] [Related]
14. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Delgado C; Song S; Hintze T; Cachofeiro V; Lahera V
J Cardiovasc Pharmacol; 2011 Jan; 57(1):114-21. PubMed ID: 20980916
[TBL] [Abstract][Full Text] [Related]
15. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats.
Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O
Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494
[TBL] [Abstract][Full Text] [Related]
16. Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats.
Jin L; Ying Z; Hilgers RH; Yin J; Zhao X; Imig JD; Webb RC
J Pharmacol Exp Ther; 2006 Jul; 318(1):288-95. PubMed ID: 16569756
[TBL] [Abstract][Full Text] [Related]
17. Betaxolol stimulates eNOS production associated with LOX-1 and VEGF in Dahl salt-sensitive rats.
Kobayashi N; Yoshida K; Mita S; Honda T; Hara K; Nakano S; Tsubokou Y; Matsuoka H
J Hypertens; 2004 Jul; 22(7):1397-402. PubMed ID: 15201557
[TBL] [Abstract][Full Text] [Related]
18. Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts.
Kobayashi N; Horinaka S; Mita S; Nakano S; Honda T; Yoshida K; Kobayashi T; Matsuoka H
Cardiovasc Res; 2002 Sep; 55(4):757-67. PubMed ID: 12176125
[TBL] [Abstract][Full Text] [Related]
19. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
20. Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure.
Karram T; Abbasi A; Keidar S; Golomb E; Hochberg I; Winaver J; Hoffman A; Abassi Z
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1351-8. PubMed ID: 15894569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
